12/22
10:00 am
nari
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Medium
Report
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
12/18
10:19 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $50.00 to $63.00. They now have a "hold" rating on the stock.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $50.00 to $63.00. They now have a "hold" rating on the stock.
12/18
10:00 am
nari
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation
12/17
08:15 am
nari
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $75.00 price target on the stock.
12/15
10:00 am
nari
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation
Low
Report
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation
12/12
05:45 pm
nari
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the Firm
Low
Report
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the Firm
12/4
09:30 am
nari
Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
Low
Report
Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
12/3
01:08 pm
nari
Okami Medical Appoints Bill Hoffman to its Board of Directors [Yahoo! Finance]
Low
Report
Okami Medical Appoints Bill Hoffman to its Board of Directors [Yahoo! Finance]
12/3
07:42 am
nari
Inari Medical enters China distribution partnership [Yahoo! Finance]
Low
Report
Inari Medical enters China distribution partnership [Yahoo! Finance]
12/2
04:19 pm
nari
Inari Medical Announces Joint Venture in Greater China [Yahoo! Finance]
Low
Report
Inari Medical Announces Joint Venture in Greater China [Yahoo! Finance]
12/2
04:09 pm
nari
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd. [Yahoo! Finance]
Low
Report
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd. [Yahoo! Finance]
12/2
04:06 pm
nari
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
Low
Report
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
12/2
04:05 pm
nari
Inari Medical Announces Joint Venture in Greater China
Low
Report
Inari Medical Announces Joint Venture in Greater China
11/18
10:03 am
nari
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance Canada]
Low
Report
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance Canada]
11/18
10:02 am
nari
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance]
Low
Report
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance]
11/7
09:08 am
nari
Is Inari Medical (NARI) Trading at an Attractive Valuation? [Yahoo! Finance]
Low
Report
Is Inari Medical (NARI) Trading at an Attractive Valuation? [Yahoo! Finance]
11/6
04:05 pm
nari
Inari Medical to Participate in the Jefferies London Healthcare Conference
Low
Report
Inari Medical to Participate in the Jefferies London Healthcare Conference
10/29
01:23 pm
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $46.00 to $50.00. They now have a "hold" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $46.00 to $50.00. They now have a "hold" rating on the stock.
10/29
11:56 am
nari
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
Low
Report
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
10/29
08:16 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $71.00 to $74.00. They now have a "buy" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $71.00 to $74.00. They now have a "buy" rating on the stock.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Piper Sandler from $50.00 to $52.00. They now have a "neutral" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Piper Sandler from $50.00 to $52.00. They now have a "neutral" rating on the stock.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Robert W. Baird from $66.00 to $67.00. They now have an "outperform" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Robert W. Baird from $66.00 to $67.00. They now have an "outperform" rating on the stock.
10/28
04:05 pm
nari
Inari Medical Reports Third Quarter 2024 Financial Results
High
Report
Inari Medical Reports Third Quarter 2024 Financial Results
10/28
03:02 am
nari
Inari Medical: A $4 Billion Opportunity Is Wide Open [Seeking Alpha]
Low
Report
Inari Medical: A $4 Billion Opportunity Is Wide Open [Seeking Alpha]